Editas Medicine Competitors and Similar CompaniesClear all
Editas Medicine's competitors and similar companies include Amyris and Nuclera.
 Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. |  Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. | ||
Founding Date | Founding Date 2013 | Founding Date 2003 | Founding Date 2013 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Emeryville, US HQ Sao Paulo, BR | Locations Cambridge, GB HQ |
Employees | Employees 20816% increase | Employees 1,0031% decrease | Employees 1192% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) $269.8m (FY, 2022) | Revenue (est.) N/A |
Net income | Net income ($160.1m) (FY, 2025) | Net income ($543.4m) (FY, 2022) | Net income N/A |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 34m (about 7 years ago) | Latest funding round $ 10m (over 7 years ago) |
Total funding raised | Total funding raised $ 210m | Total funding raised $ 551.9m | Total funding raised $ 11.3m |
For sources of this data, please see the company profile
View Company Profiles
Amyris
HQ
Emeryville, US
Employees
1,003↓ 1% decrease
Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation.
View company
Nuclera
HQ
Cambridge, GB
Employees
119↓ 2% decrease
Nuclera is a company that specializes in DNA synthesis.
View company